nodes	percent_of_prediction	percent_of_DWPC	metapath
Salbutamol—CYP3A4—Rifampicin—leprosy	0.153	0.548	CbGbCtD
Salbutamol—CYP3A4—Dapsone—leprosy	0.127	0.452	CbGbCtD
Salbutamol—Application site reaction—Dapsone—leprosy	0.0355	0.0512	CcSEcCtD
Salbutamol—Clenbuterol—TNF—leprosy	0.0186	0.704	CrCbGaD
Salbutamol—Tongue discolouration—Thalidomide—leprosy	0.0176	0.0254	CcSEcCtD
Salbutamol—Lung disorder—Thalidomide—leprosy	0.012	0.0174	CcSEcCtD
Salbutamol—Hyperaesthesia—Thalidomide—leprosy	0.0109	0.0157	CcSEcCtD
Salbutamol—Nasopharyngitis—Dapsone—leprosy	0.0108	0.0156	CcSEcCtD
Salbutamol—Myocardial ischaemia—Thalidomide—leprosy	0.0106	0.0153	CcSEcCtD
Salbutamol—Influenza—Dapsone—leprosy	0.0104	0.0151	CcSEcCtD
Salbutamol—Vasodilation—Thalidomide—leprosy	0.0097	0.014	CcSEcCtD
Salbutamol—Vasodilation procedure—Thalidomide—leprosy	0.0097	0.014	CcSEcCtD
Salbutamol—Accidental injury—Thalidomide—leprosy	0.00963	0.0139	CcSEcCtD
Salbutamol—Viral infection—Thalidomide—leprosy	0.00943	0.0136	CcSEcCtD
Salbutamol—Thinking abnormal—Thalidomide—leprosy	0.00931	0.0134	CcSEcCtD
Salbutamol—Herpes simplex—Thalidomide—leprosy	0.00925	0.0133	CcSEcCtD
Salbutamol—Neuropathy peripheral—Dapsone—leprosy	0.00913	0.0132	CcSEcCtD
Salbutamol—Sinusitis—Dapsone—leprosy	0.00874	0.0126	CcSEcCtD
Salbutamol—Eructation—Thalidomide—leprosy	0.00837	0.0121	CcSEcCtD
Salbutamol—Pharyngitis—Dapsone—leprosy	0.0083	0.012	CcSEcCtD
Salbutamol—Cramps of lower extremities—Thalidomide—leprosy	0.00783	0.0113	CcSEcCtD
Salbutamol—Epinephrine—TNF—leprosy	0.00781	0.296	CrCbGaD
Salbutamol—Tinnitus—Dapsone—leprosy	0.00779	0.0112	CcSEcCtD
Salbutamol—Lightheadedness—Thalidomide—leprosy	0.00762	0.011	CcSEcCtD
Salbutamol—Pulmonary oedema—Thalidomide—leprosy	0.00759	0.0109	CcSEcCtD
Salbutamol—Hypertonia—Thalidomide—leprosy	0.00747	0.0108	CcSEcCtD
Salbutamol—Hyperkinesia—Thalidomide—leprosy	0.00743	0.0107	CcSEcCtD
Salbutamol—Mental disability—Thalidomide—leprosy	0.00739	0.0107	CcSEcCtD
Salbutamol—Euphoric mood—Thalidomide—leprosy	0.00732	0.0106	CcSEcCtD
Salbutamol—Lymphadenopathy—Thalidomide—leprosy	0.00725	0.0105	CcSEcCtD
Salbutamol—Diabetes mellitus—Thalidomide—leprosy	0.00711	0.0103	CcSEcCtD
Salbutamol—Gastroenteritis—Thalidomide—leprosy	0.00698	0.0101	CcSEcCtD
Salbutamol—Eczema—Thalidomide—leprosy	0.00688	0.00993	CcSEcCtD
Salbutamol—Injury—Thalidomide—leprosy	0.00673	0.0097	CcSEcCtD
Salbutamol—Increased appetite—Thalidomide—leprosy	0.00658	0.00949	CcSEcCtD
Salbutamol—Vertigo—Dapsone—leprosy	0.00654	0.00943	CcSEcCtD
Salbutamol—Atrial fibrillation—Thalidomide—leprosy	0.00653	0.00941	CcSEcCtD
Salbutamol—Cough—Dapsone—leprosy	0.00635	0.00916	CcSEcCtD
Salbutamol—Hypoglycaemia—Thalidomide—leprosy	0.00634	0.00914	CcSEcCtD
Salbutamol—Migraine—Thalidomide—leprosy	0.00609	0.00878	CcSEcCtD
Salbutamol—Affect lability—Thalidomide—leprosy	0.00609	0.00878	CcSEcCtD
Salbutamol—Mood swings—Thalidomide—leprosy	0.00586	0.00845	CcSEcCtD
Salbutamol—Ataxia—Thalidomide—leprosy	0.00582	0.00839	CcSEcCtD
Salbutamol—Tachycardia—Dapsone—leprosy	0.0058	0.00836	CcSEcCtD
Salbutamol—Hypokalaemia—Thalidomide—leprosy	0.00563	0.00812	CcSEcCtD
Salbutamol—Cramp muscle—Thalidomide—leprosy	0.00557	0.00803	CcSEcCtD
Salbutamol—Abdominal distension—Thalidomide—leprosy	0.00538	0.00776	CcSEcCtD
Salbutamol—Insomnia—Dapsone—leprosy	0.00537	0.00775	CcSEcCtD
Salbutamol—Influenza—Thalidomide—leprosy	0.00535	0.00771	CcSEcCtD
Salbutamol—Bronchospasm—Thalidomide—leprosy	0.00526	0.00758	CcSEcCtD
Salbutamol—Angina pectoris—Thalidomide—leprosy	0.00521	0.00751	CcSEcCtD
Salbutamol—Bronchitis—Thalidomide—leprosy	0.00514	0.00741	CcSEcCtD
Salbutamol—Upper respiratory tract infection—Thalidomide—leprosy	0.00497	0.00716	CcSEcCtD
Salbutamol—Gastrointestinal pain—Dapsone—leprosy	0.00486	0.007	CcSEcCtD
Salbutamol—Hyperglycaemia—Thalidomide—leprosy	0.00482	0.00695	CcSEcCtD
Salbutamol—Drowsiness—Thalidomide—leprosy	0.00477	0.00687	CcSEcCtD
Salbutamol—Body temperature increased—Dapsone—leprosy	0.00469	0.00677	CcSEcCtD
Salbutamol—Abdominal pain—Dapsone—leprosy	0.00469	0.00677	CcSEcCtD
Salbutamol—Neuropathy peripheral—Thalidomide—leprosy	0.00467	0.00674	CcSEcCtD
Salbutamol—Stomatitis—Thalidomide—leprosy	0.00465	0.0067	CcSEcCtD
Salbutamol—Conjunctivitis—Thalidomide—leprosy	0.00463	0.00668	CcSEcCtD
Salbutamol—Sweating—Thalidomide—leprosy	0.00457	0.00659	CcSEcCtD
Salbutamol—Haematuria—Thalidomide—leprosy	0.00455	0.00655	CcSEcCtD
Salbutamol—Epistaxis—Thalidomide—leprosy	0.0045	0.00648	CcSEcCtD
Salbutamol—Sinusitis—Thalidomide—leprosy	0.00447	0.00645	CcSEcCtD
Salbutamol—Rhinitis—Thalidomide—leprosy	0.00429	0.00619	CcSEcCtD
Salbutamol—Hypoaesthesia—Thalidomide—leprosy	0.00426	0.00614	CcSEcCtD
Salbutamol—Pharyngitis—Thalidomide—leprosy	0.00425	0.00612	CcSEcCtD
Salbutamol—Urinary tract disorder—Thalidomide—leprosy	0.00423	0.00609	CcSEcCtD
Salbutamol—Urethral disorder—Thalidomide—leprosy	0.00419	0.00605	CcSEcCtD
Salbutamol—Tinnitus—Thalidomide—leprosy	0.00399	0.00575	CcSEcCtD
Salbutamol—Cardiac disorder—Thalidomide—leprosy	0.00397	0.00573	CcSEcCtD
Salbutamol—Angiopathy—Thalidomide—leprosy	0.00388	0.0056	CcSEcCtD
Salbutamol—Immune system disorder—Thalidomide—leprosy	0.00387	0.00557	CcSEcCtD
Salbutamol—Mediastinal disorder—Thalidomide—leprosy	0.00386	0.00556	CcSEcCtD
Salbutamol—Chills—Thalidomide—leprosy	0.00384	0.00554	CcSEcCtD
Salbutamol—Arrhythmia—Thalidomide—leprosy	0.00382	0.00551	CcSEcCtD
Salbutamol—Vomiting—Dapsone—leprosy	0.00378	0.00544	CcSEcCtD
Salbutamol—Mental disorder—Thalidomide—leprosy	0.00375	0.00541	CcSEcCtD
Salbutamol—Malnutrition—Thalidomide—leprosy	0.00373	0.00537	CcSEcCtD
Salbutamol—Headache—Dapsone—leprosy	0.00372	0.00536	CcSEcCtD
Salbutamol—Flatulence—Thalidomide—leprosy	0.00367	0.00529	CcSEcCtD
Salbutamol—Tension—Thalidomide—leprosy	0.00366	0.00527	CcSEcCtD
Salbutamol—Dysgeusia—Thalidomide—leprosy	0.00365	0.00526	CcSEcCtD
Salbutamol—Nervousness—Thalidomide—leprosy	0.00362	0.00522	CcSEcCtD
Salbutamol—Back pain—Thalidomide—leprosy	0.0036	0.0052	CcSEcCtD
Salbutamol—Muscle spasms—Thalidomide—leprosy	0.00358	0.00516	CcSEcCtD
Salbutamol—Nausea—Dapsone—leprosy	0.00353	0.00509	CcSEcCtD
Salbutamol—Tremor—Thalidomide—leprosy	0.00349	0.00503	CcSEcCtD
Salbutamol—Ill-defined disorder—Thalidomide—leprosy	0.00346	0.00498	CcSEcCtD
Salbutamol—Agitation—Thalidomide—leprosy	0.00342	0.00494	CcSEcCtD
Salbutamol—Angioedema—Thalidomide—leprosy	0.0034	0.00491	CcSEcCtD
Salbutamol—Malaise—Thalidomide—leprosy	0.00336	0.00484	CcSEcCtD
Salbutamol—Vertigo—Thalidomide—leprosy	0.00335	0.00483	CcSEcCtD
Salbutamol—Syncope—Thalidomide—leprosy	0.00334	0.00482	CcSEcCtD
Salbutamol—Palpitations—Thalidomide—leprosy	0.00329	0.00475	CcSEcCtD
Salbutamol—Loss of consciousness—Thalidomide—leprosy	0.00327	0.00472	CcSEcCtD
Salbutamol—Cough—Thalidomide—leprosy	0.00325	0.00469	CcSEcCtD
Salbutamol—Hypertension—Thalidomide—leprosy	0.00322	0.00464	CcSEcCtD
Salbutamol—Chest pain—Thalidomide—leprosy	0.00317	0.00457	CcSEcCtD
Salbutamol—Myalgia—Thalidomide—leprosy	0.00317	0.00457	CcSEcCtD
Salbutamol—Arthralgia—Thalidomide—leprosy	0.00317	0.00457	CcSEcCtD
Salbutamol—Anxiety—Thalidomide—leprosy	0.00316	0.00456	CcSEcCtD
Salbutamol—Discomfort—Thalidomide—leprosy	0.00313	0.00452	CcSEcCtD
Salbutamol—Dry mouth—Thalidomide—leprosy	0.0031	0.00447	CcSEcCtD
Salbutamol—Oedema—Thalidomide—leprosy	0.00304	0.00438	CcSEcCtD
Salbutamol—Infection—Thalidomide—leprosy	0.00302	0.00436	CcSEcCtD
Salbutamol—Shock—Thalidomide—leprosy	0.00299	0.00431	CcSEcCtD
Salbutamol—Nervous system disorder—Thalidomide—leprosy	0.00298	0.0043	CcSEcCtD
Salbutamol—Tachycardia—Thalidomide—leprosy	0.00297	0.00428	CcSEcCtD
Salbutamol—Skin disorder—Thalidomide—leprosy	0.00295	0.00426	CcSEcCtD
Salbutamol—Hyperhidrosis—Thalidomide—leprosy	0.00294	0.00424	CcSEcCtD
Salbutamol—Anorexia—Thalidomide—leprosy	0.0029	0.00418	CcSEcCtD
Salbutamol—Hypotension—Thalidomide—leprosy	0.00284	0.0041	CcSEcCtD
Salbutamol—Musculoskeletal discomfort—Thalidomide—leprosy	0.00277	0.00399	CcSEcCtD
Salbutamol—Insomnia—Thalidomide—leprosy	0.00275	0.00397	CcSEcCtD
Salbutamol—Paraesthesia—Thalidomide—leprosy	0.00273	0.00394	CcSEcCtD
Salbutamol—Dyspnoea—Thalidomide—leprosy	0.00271	0.00391	CcSEcCtD
Salbutamol—Somnolence—Thalidomide—leprosy	0.0027	0.0039	CcSEcCtD
Salbutamol—Dyspepsia—Thalidomide—leprosy	0.00268	0.00386	CcSEcCtD
Salbutamol—Decreased appetite—Thalidomide—leprosy	0.00264	0.00381	CcSEcCtD
Salbutamol—Gastrointestinal disorder—Thalidomide—leprosy	0.00262	0.00378	CcSEcCtD
Salbutamol—Fatigue—Thalidomide—leprosy	0.00262	0.00378	CcSEcCtD
Salbutamol—Pain—Thalidomide—leprosy	0.0026	0.00375	CcSEcCtD
Salbutamol—Constipation—Thalidomide—leprosy	0.0026	0.00375	CcSEcCtD
Salbutamol—Feeling abnormal—Thalidomide—leprosy	0.00251	0.00361	CcSEcCtD
Salbutamol—Gastrointestinal pain—Thalidomide—leprosy	0.00249	0.00358	CcSEcCtD
Salbutamol—Urticaria—Thalidomide—leprosy	0.00242	0.00348	CcSEcCtD
Salbutamol—Abdominal pain—Thalidomide—leprosy	0.0024	0.00347	CcSEcCtD
Salbutamol—Body temperature increased—Thalidomide—leprosy	0.0024	0.00347	CcSEcCtD
Salbutamol—Hypersensitivity—Thalidomide—leprosy	0.00224	0.00323	CcSEcCtD
Salbutamol—Asthenia—Thalidomide—leprosy	0.00218	0.00315	CcSEcCtD
Salbutamol—Pruritus—Thalidomide—leprosy	0.00215	0.0031	CcSEcCtD
Salbutamol—Diarrhoea—Thalidomide—leprosy	0.00208	0.003	CcSEcCtD
Salbutamol—Dizziness—Thalidomide—leprosy	0.00201	0.0029	CcSEcCtD
Salbutamol—Vomiting—Thalidomide—leprosy	0.00193	0.00279	CcSEcCtD
Salbutamol—Rash—Thalidomide—leprosy	0.00192	0.00276	CcSEcCtD
Salbutamol—Dermatitis—Thalidomide—leprosy	0.00192	0.00276	CcSEcCtD
Salbutamol—Headache—Thalidomide—leprosy	0.0019	0.00275	CcSEcCtD
Salbutamol—Nausea—Thalidomide—leprosy	0.00181	0.0026	CcSEcCtD
